PeptidePedia The community reference

Source of Drug master file

Page source·read-only·revision 33

Editing is disabled on this mirror. This is the page source as of revision 33, saved by CiteBot on 17 July 2026. It is shown so that the markup behind the rendered article can be read and reused under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).

4,325 bytes · 61 lines · 3 top-level sections · 6 defined citations. The markup grammar is documented at Project:Manual of style.

{{Infobox concept | name = Drug master file | subtitle = Regulatory mechanism | Abbreviation = DMF | Contains = Confidential manufacturing and control detail | Referenced by = A customer, with a letter of authorisation | Not = An approval or a certification }} A '''drug master file''' ('''DMF''') is a submission to a medicines regulator containing confidential detail about the manufacture, processing and control of a substance. Its purpose is to allow a customer's application to reference that detail without the holder disclosing it to the customer.{{r|fda_dmf}} A DMF is not an approval. Filing one causes it to be assigned a number and acknowledged; the regulator reviews its content only when an application referencing it is reviewed, and a review finding may be adverse.{{r|fda_dmf}} Equivalent mechanisms exist elsewhere — the European certificate of suitability to the monographs of the European Pharmacopoeia is the closest analogue, though it differs in being an assessment rather than a repository.{{r|edqm_cep}} == How the mechanism works == The holder files the document with the regulator. When a customer submits an application using that substance, the holder issues a letter of authorisation permitting the regulator to review the file in support of that application.{{r|fda_dmf}} The customer never sees the confidential content. This solves a genuine commercial problem: a manufacturer's process is often its principal asset, and disclosure to a customer who may be a competitor's supplier is unattractive. Because review occurs only in the context of an application, an unreferenced file has never been assessed. A statement that a substance "has a DMF" therefore says that a document exists, not that it has been found adequate.{{r|fda_dmf}} == What a DMF claim establishes == | Claim | What it establishes | |---|---| | A DMF has been filed | A document exists with a number | | A DMF has been referenced | A regulator has reviewed it for one application | | A DMF has no outstanding deficiencies | Review occurred and was satisfactory | | Nothing further | The material in a given vial | The last row matters here. A DMF describes a process and its controls for a substance intended as an [[Active pharmaceutical ingredient|active pharmaceutical ingredient]]. Material sold as a research chemical is not that substance in the regulatory sense, even where the chemistry is identical.{{r|ich_q7}} DMF numbers are published in regulator lists, so the existence of a filing is checkable. Its status generally is not.{{r|fda_dmf}} == Relevance to this wiki == Supplier documentation sometimes cites a DMF number as evidence of quality. It is evidence of a filing, which is a real thing and a checkable one, and it is not evidence about a research-chemical lot.{{r|reports}} The general shape is the same as for [[ISO 9001]] and [[Good manufacturing practice|GMP]] claims: each is a genuine and verifiable claim about an organisation or a process, each is checkable with particulars, and none is a statement about the material in a vial.{{r|iso9001}} That is a documentary observation and not an allegation about any organisation.{{r|usp1503}} == References == {{reflist}} <ref name="fda_dmf">United States Food and Drug Administration, ''Drug Master Files: Guidelines'' and the published DMF list.</ref> <ref name="edqm_cep">European Directorate for the Quality of Medicines, ''Certification of Suitability to the Monographs of the European Pharmacopoeia'' procedure.</ref> <ref name="ich_q7">International Council for Harmonisation, ''Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients'' (2000).</ref> <ref name="iso9001">ISO 9001:2015, ''Quality management systems — Requirements''.</ref> <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> == See also == * [[Active pharmaceutical ingredient]] * [[Good manufacturing practice]] * [[ISO 9001]] * [[Certificate of analysis]] {{DEFAULTSORT:Drug master file}} [[Category:Drug regulation]] [[Category:Good manufacturing practice]] [[Category:Regulation and law]]

Templates in this source are rendered by the site generator: {{r|id}} becomes a numbered citation, {{figure|key|caption}} a framed diagram, {{main|Title}} a cross-reference line.